- Home
- BV vs MDXG Comparison
BV vs MDXG Comparison
Compare BV & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BV
- MDXG
- Stock Information
- Founded
- BV 1939
- MDXG 2006
- Country
- BV United States
- MDXG United States
- Employees
- BV N/A
- MDXG N/A
- Industry
- BV Business Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- BV Consumer Discretionary
- MDXG Health Care
- Exchange
- BV Nasdaq
- MDXG Nasdaq
- Market Cap
- BV 1.4B
- MDXG 1.2B
- IPO Year
- BV 2018
- MDXG N/A
- Fundamental
- Price
- BV $13.46
- MDXG $8.01
- Analyst Decision
- BV Buy
- MDXG Strong Buy
- Analyst Count
- BV 8
- MDXG 5
- Target Price
- BV $17.41
- MDXG $12.00
- AVG Volume (30 Days)
- BV 717.5K
- MDXG 463.5K
- Earning Date
- BV 02-05-2025
- MDXG 02-26-2025
- Dividend Yield
- BV N/A
- MDXG N/A
- EPS Growth
- BV N/A
- MDXG N/A
- EPS
- BV 0.27
- MDXG 0.52
- Revenue
- BV $2,739,600,000.00
- MDXG $342,804,000.00
- Revenue This Year
- BV $3.39
- MDXG $9.56
- Revenue Next Year
- BV $3.64
- MDXG $9.19
- P/E Ratio
- BV $50.75
- MDXG $15.45
- Revenue Growth
- BV N/A
- MDXG 10.93
- 52 Week Low
- BV $8.52
- MDXG $5.47
- 52 Week High
- BV $18.89
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- BV 29.56
- MDXG 37.18
- Support Level
- BV $13.24
- MDXG $7.82
- Resistance Level
- BV $14.02
- MDXG $8.10
- Average True Range (ATR)
- BV 0.55
- MDXG 0.23
- MACD
- BV -0.12
- MDXG -0.02
- Stochastic Oscillator
- BV 10.04
- MDXG 23.81
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.